We have advanced the knowledge by demonstrating that the inactivation of PCSK6 can significantly inhibit the Raf-MEK1/2-ERK1/2 axis, having a repressive effect on cell growth, cell migration and the generation of metastatic niches in the liver in pancreatic cancer. Here, MAPK3 is linked to pancreatic neoplasm.